Demand for the amniocentesis needles is expected to gain momentum attributed to growing need for removing excessive amniotic fluid from around the baby. Excessive amniotic fluid during pregnancy leads to increasing risks of complication. In addition, growing number of complications during pregnancy such as twin-to-twin transfusion, diabetes, and RH incompatibility will continue to impact growth of the global amniocentesis market positively. During pregnancy, the baby swallows amniotic fluid as a practice for real-life breathing. Prevalence of placental tumor and gestational diabetes also leads to an excess of amniotic fluid, which is further expected to contribute towards growth of the global amniocentesis needles market during the forecast period.
Request for the Report Summary: https://www.factmr.com/report/362/amniocentesis-needle-market
Growing need to check for infections, birth defects, genetic problems and lung development has led to surge in demand for the amniocentesis needles globally. Prevalence of diabetes among the pregnant women can further lead to excessive buildup of amniotic fluid. According to CDC, 2% to 10% of pregnancies in the U.S. is effected by gestational diabetes every year. Prevalence of diabetes among the pregnant women and increasing level of blood glucose has led to the growing need for removing excessive fluid from around the baby. Instances of miscarriage, vaginal bleeding, and infection to the baby and leaking amniotic fluid has further led to surge in demand for transabdominal sampling of the amniotic fluid.
Increasing demand for conducting biochemical and cytogenetic research studies is further expected to contribute towards growth of the global amniocentesis needle market. Surge in private and government investment in order to upgrade and develop clinics and hospitals has led to increasing number of research and development. Growing investment in research and development for upgrading the clinics and hospitals is expected to contribute towards growth of the global amniocentesis needle market throughout the forecast period.
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=362
Growing need to remove excessive amniotic needle has led to surge in demand for amniocentesis needle of 100 - 150 mm length. On the basis of size, the 100 - 150 mm segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. In contrary, the larger than 150 mm size segment is expected to register a significant CAGR throughout the forecast period.
Based on end users, the hospitals segment is expected to witness a significant revenue growth, recording for a value of over US$ 26 Mn by the end of 2017. On the other hand, the other end users segment is expected to register a robust CAGR during the forecast period.
By procedure, the amniocentesis segment is expected to generate significant revenues, accounting for a value of over US$ 20 Mn by the end of 2026. However, the cordocentesis procedure segment is expected to register the highest CAGR throughout the forecast period.
Request for the Report Customization: https://www.factmr.com/connectus/sample?flag=RC&rep_id=362
Fact.MRâ€™s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level â€" our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.
Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.
The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.
27 Upper Pembroke Street,
Dublin 2, Ireland